Janus Henderson Group PLC Immunic, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Immunic, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 7,073,844 shares of IMUX stock, worth $8.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,073,844
Previous 6,993,007
1.16%
Holding current value
$8.35 Million
Previous $9.23 Million
14.94%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IMUX
# of Institutions
67Shares Held
56MCall Options Held
4.7KPut Options Held
311K-
Avidity Partners Management LP Dallas, TX8.9MShares$10.5 Million0.49% of portfolio
-
Bvf Inc San Francisco, CA8.9MShares$10.5 Million0.3% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$8.61 Million0.82% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$6.6 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$5.39 Million0.08% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $36.1M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...